In breast cancer, elevated MCF2L-AS1 expression predicts shortened patient survival,18 while in colorectal cancer, it drives tumor progression by sponging miR-105–5p to promote RAB22A-mediated metastasis.12 This evidence concerns the gene RAB22A and breast carcinoma.